Catalyst Wire Dossier Catalyst Wire Dossier

Ezetimibe/atorvastatin 10 mg/20 mg fixed-dose combination tablet

ezetimibe/atorvastatin · Organon and Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ezetimibe/atorvastatin 10 mg/20 mg fixed-dose combination tablet, covering 2013-08-05 to 2013-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) [Phase 3]

See pricing